Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets

v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 77,742,669 $ 56,490,579
Marketable securities 9,923,100 41,052,949
Prepaid research and development 138,855 81,308
Deferred offering costs 307,373 0
Prepaid expenses and other current assets 682,628 826,473
Total current assets 88,794,625 98,451,309
Equipment and improvements, net 23,687 47,100
Right-of-use asset 34,918 101,437
Total assets 88,853,230 98,599,846
Current liabilities:    
Accounts payable 2,703,554 943,019
Lease obligation, current 37,944 110,517
Accrued expenses and other current liabilities 3,145,888 2,680,030
Contingent consideration liability 2,912,159 0
Total current liabilities 8,799,545 3,733,566
Total liabilities 8,799,545 3,733,566
Commitments and contingencies (see Note 15)
Stockholders’ equity:    
Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at June 30, 2025 and December 31, 2024 0 0
Common stock, $0.001 par value; 500,000,000 and 100,000,000 shares authorized; 74,516,635 and 69,362,439 shares issued and outstanding (including 4,149,252 and 0 contingently issuable shares - see Note 10) at June 30, 2025 and December 31, 2024, respectively 74,516 69,362
Additional paid-in capital 197,996,982 189,254,777
Accumulated other comprehensive loss (2,944) (37,248)
Accumulated deficit (118,014,869) (94,420,611)
Total stockholders' equity 80,053,685 94,866,280
Total liabilities and stockholders' equity $ 88,853,230 $ 98,599,846